Jw Pharmaceutical Corporation (001060.XKRX) Dividend Analysis
Does Jw Pharmaceutical (001060.XKRX) pay a dividend?
Yes. Jw Pharmaceutical (001060.XKRX) pays a dividend: KRW 650.00 per share over the last twelve months, a dividend yield of 2.40% at the latest close.
It has raised its dividend per share for at least 4 years in a row (every year of the history we hold), growing at 21.0% a year over the last 4 years. The payout takes about 14.5% of earnings.
Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.
| Fiscal year | Per share | Change |
|---|---|---|
| 2025 | KRW 650.00 | +44.4% |
| 2024 | KRW 450.00 | +12.5% |
| 2023 | KRW 400.00 | +14.3% |
| 2022 | KRW 349.94 | +15.4% |
| 2021 | KRW 303.28 |
All 5 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.
Dividend appears well-covered by both earnings and free cash flow.
Based on TTM and annual data · Not a buy/sell signal
Score Breakdown
Safety
40% of composite
Growth
35% of composite
Income
25% of composite
Composite = Safety (100) × 0.40 + Growth (73) × 0.35 + Income (70) × 0.25 = 83
Dividend Yield
2.40%
Per Share (TTM)
KRW 650.00
Payout Ratio
14.5%
4Y CAGR
21.0%
Dividend Safety
Earnings Payout
14.5%
FCF Payout
14.6%
FCF Coverage
6.8x
Dividend Growth
Per Share (TTM)
KRW 650.00
Growth Streak
4+ years
4Y CAGR
21.0%
Dividend Income
Annual DPS (TTM)
KRW 650.00
Annual Income / KRW 10K
KRW 240
Payment frequency, ex-dividend and payment dates are not available from company filings. Check your broker or the company's investor relations page for the schedule.
Yield History
Jw Pharmaceutical (001060.XKRX) dividend: yield, safety and growth
Frequently asked
Does Jw Pharmaceutical (001060.XKRX) pay a dividend, and how much?+
Yes, Jw Pharmaceutical pays a regular dividend of about KRW 650.00 per share per year (a yield of roughly 2.4%). That is a payout ratio of about 14.5% of earnings, so it is comfortably covered by free cash flow. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.
Is Jw Pharmaceutical's dividend safe?+
Jw Pharmaceutical's dividend looks comfortably covered by free cash flow, with free cash flow covering the payout about 6.8 times over. Intrinsiqq scores its dividend safety at 100 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.
Has Jw Pharmaceutical grown its dividend?+
Jw Pharmaceutical has raised its dividend for at least 4 years in a row, the full span of the dividend history we hold. Over the past five years the dividend has grown at roughly 21.0% a year. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.
What is Jw Pharmaceutical's dividend payout ratio?+
Jw Pharmaceutical pays out about 14.5% of its earnings as dividends. A lower payout ratio leaves more room to keep raising the dividend and to absorb a bad year, while a very high ratio can signal a payout under pressure. On this measure the dividend is comfortably covered by free cash flow. See the dividend-safety breakdown for the free-cash-flow view, which is often more telling than earnings.
Related stocks: Drug Manufacturers - Specialty & Generic
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.